Nisa Investment Advisors
ABEO icon

Nisa Investment Advisors’s Abeona Therapeutics ABEO Stock Holding History

Nisa Investment Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2K Buy
+4,571
New +$25.1K ﹤0.01% 2081
2021
Q4 		– Sell
-79
Closed -$2K – 2139
2021
Q3 		$2K Hold
79
– – ﹤0.01% 2286
2021
Q2 		$3K Hold
79
– – ﹤0.01% 2291
2021
Q1 		$4K Hold
79
– – ﹤0.01% 2262
2020
Q4 		$3K Hold
79
– – ﹤0.01% 2276
2020
Q3 		$2K Buy
79
+27
+52% +$1.7K ﹤0.01% 2231
2020
Q2 		$4K Hold
52
– – ﹤0.01% 2016
2020
Q1 		$3K Buy
+52
New +$3.47K ﹤0.01% 1995
2019
Q3 		– Sell
-800
Closed -$96K – 2009
2019
Q2 		$96K Sell
800
-708
-47% -$119K ﹤0.01% 1424
2019
Q1 		$277K Buy
1,508
+400
+36% +$71.5K ﹤0.01% 1218
2018
Q4 		$198K Buy
+1,108
New +$242K ﹤0.01% 1243

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nisa Investment Advisors's ABEO Position: Q2 2026 in Review

Nisa Investment Advisors opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 4,571 shares worth $28.2K. The stake represents ﹤0.01% of the portfolio and ranks #2081 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in ABEO as recently as Q3 2021.

Nisa Investment Advisors first reported a position in ABEO in Q4 2018 and has held it in 11 quarters since. The position peaked at $277K in Q1 2019. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Nisa Investment Advisors held 4,571 shares of Abeona Therapeutics worth $28.2K as of Q2 2026.
  • Abeona Therapeutics was a new Nisa Investment Advisors position in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2081 holding.
  • Nisa Investment Advisors first reported a position in Abeona Therapeutics in Q4 2018 and has held it in 11 quarters since.
  • Nisa Investment Advisors's Abeona Therapeutics position peaked at $277K in Q1 2019.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.